New insider Wheeler Ashlee claimed ownership of 126,377 shares (SEC Form 3)
$CURV
Clothing/Shoe/Accessory Stores
Consumer Discretionary
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/18/2025 |
3. Issuer Name and Ticker or Trading Symbol
Torrid Holdings Inc. [ CURV ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 126,377(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Option to purchase shares | (2) | 06/30/2031 | Common Stock | 9,524 | $21 | D | |
| Option to purchase shares | (3) | 03/31/2032 | Common Stock | 14,577 | $6.06 | D | |
| Option to purchase shares | (4) | 09/02/2032 | Common Stock | 36,983 | $5.75 | D | |
| Option to purchase shares | (5) | 03/27/2033 | Common Stock | 64,433 | $3.23 | D | |
| Option to purchase shares | (6) | 04/02/2034 | Common Stock | 44,965 | $4.51 | D | |
| Option to purchase shares | (7) | 07/01/2034 | Common Stock | 11,038 | $7.42 | D | |
| Option to purchase shares | (8) | 03/25/2035 | Common Stock | 56,819 | $5.6 | D | |
| Explanation of Responses: |
| 1. Represents (1) 34,125 shares of common stock outstanding, (2) 1,192 restricted stock units (RSUs) that remain unvested from a grant of 4,762 RSUs which started vesting on July 6, 2022; (3) 2,063 RSUs that remain unvested from a grant of 8,251 RSUs which started vesting on March 31, 2023t; (4) 10,870 RSUs that remain unvested from a grant of 21,740 RSUs which started vesting on September 2, 2023; (5) 19,350 RSUs that remain unvested from a grant of 38,700 RSUs which started vesting on March 27, 2024; (6) 20,788 RSUs that remain unvested from a grant of 27,717 RSUs which started vesting on April 2, 2025; (7) 6,739 RSUs that remain unvested from a grant of 6,739 RSUs which will start to vest on July 1, 2025; (8) 31,250 RSUs that remain unvested from a grant of 31,250 RSUs which will start to vest on March 25, 2026. All grants of RSUs vest in substantially equal 25% installments. Vesting is subject to the reporting person's continued employment through the applicable vesting date. |
| 2. Represents options to purchase shares that started vesting on June 30, 2022 and become exercisable in substantially equal 25% installments on each of June 30, 2022, June 30, 2023, June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through the applicable vesting date. |
| 3. Represents options to purchase shares that started vesting on March 31, 2023 and become exercisable in substantially equal 25% installments on each of March 31, 2023, March 31, 2024, March 31, 2025 and March 31, 2026, subject to the reporting person's continued employment through the applicable vesting date. |
| 4. Represents options to purchase shares that started vesting on September 2, 2023 and become exercisable in substantially equal 25% installments on each of September 2, 2023, September 2, 2024, September 2, 2025 and September 2, 2026, subject to the reporting person's continued employment through the applicable vesting date. |
| 5. Represents options to purchase shares that started vesting on March 27, 2024 and become exercisable in substantially equal 25% installments on each of March 27, 2024, March 27, 2025, March 27, 2026 and March 27, 2027, subject to the reporting person's continued employment through the applicable vesting date. |
| 6. Represents options to purchase shares that started vesting on April 2, 2025 and become exercisable in substantially equal 25% installments on each of April 2, 2025, April 2, 2026, April 2, 2027 and April 2, 2028, subject to the reporting person's continued employment through the applicable vesting date. |
| 7. Represents options to purchase shares that will start to vest on July 1, 2025 and become exercisable in substantially equal 25% installments on each of July 1, 2025, July 1, 2026, July 1, 2027 and July 1, 2028, subject to the reporting person's continued employment through the applicable vesting date. |
| 8. Represents options to purchase shares that will start to vest on March 25, 2026 and become exercisable in substantially equal 25% installments on each of March 25, 2026, March 25, 2027, March 25, 2028 and March 25, 2029, subject to the reporting person's continued employment through the applicable vesting date. |
| Remarks: |
| Title - Chief Strategy and Planning Officer; Exhibit 24 - Power of Attorney |
| /s/ Bridgett C. Zeterberg, as Attorney-in-Fact for Ashlee Wheeler | 05/16/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||